Rupalini Rawal-Dhingra, MD
Obstetrics & Gynecology · Bristol, CTNPI 1588971998
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (53.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Intuitive Surgical at 54.0% of the total. Reporting peaked in 2022 at $3,393 and has fallen 92.0% since, to $270 in 2025. Among obstetrics & gynecology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $44.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- AbbVie$419
- Astellas Pharma US Inc$416
- Therapeuticsmd, Inc.$184
- Bayer$177
- Pfizer$138
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,65047%
- Education$150%
- Other$3,00053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $3,061 |
| AbbVie(2 entities) | 20 | $419 |
| Astellas Pharma US Inc | 16 | $416 |
| Therapeuticsmd, Inc. | 10 | $184 |
| Bayer | 10 | $177 |
| Pfizer | 7 | $138 |
| Mayne Pharma Commercial LLC | 6 | $133 |
| Exact Sciences | 4 | $112 |
| Myovant Sciences Inc. | 6 | $108 |
| Phadia US Inc. | 1 | $86 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Minerva Surgical, Inc | 3 | $79 |
| Avion Pharmaceuticals | 6 | $77 |
| Exeltis, USA Inc. | 3 | $66 |
| Mylan Pharmaceuticals Inc. | 4 | $60 |
| Evofem Biosciences, Inc. | 3 | $54 |
| Coopersurgical, Inc. | 2 | $43 |
| Vertical Pharmaceuticals, LLC | 3 | $43 |
| Organon | 2 | $42 |
| Shield Therapeutics Inc | 2 | $37 |
| Merck | 2 | $37 |
| Duchesnay USA Incorporated | 2 | $35 |
| Ferring Pharmaceuticals Inc. | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Agile Therapeutics, Inc. | 1 | $23 |
| Medtronic | 1 | $20 |
| Urovant Sciences Inc | 1 | $19 |
| Smith+Nephew | 1 | $19 |
| Millicent US Inc | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
How this compares
$5,665 in reported general payments places this provider in the 90th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride ErOxybutynin Chloride | 18 | $340 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $334 |
| Estradiol | 17 | $333 |
| Alendronate Sodium | 17 | $148 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Bristol
- Mary MinkinNew Haven$285K
- Alessandro SantinNew Haven$98K
- Frederick RauHartford$89K
- Peter AuerbachGroton$41K
- Shieva GhofranyStamford$33K
- Mark LeondiresNorwalk$31K
- Alan FineHartford$30K
- Sean FlahertyHamden$28K
- Adam SteinbergHartford$23K
- Sarp AkselStamford$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.